Foretinib demonstrates anti-tumor activity and improves overall survival in preclinical models of hepatocellular carcinoma

Author： Huynh Hung   Ong Richard   Soo Khee  

Publisher： Springer Publishing Company

ISSN： 0969-6970

Source： Angiogenesis, Vol.15, Iss.1, 2012-03, pp. : 59-70

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chemoembolization Combined with Pravastatin Improves Survival in Patients with Hepatocellular Carcinoma

By  

Digestion, Vol. 78, Iss. 1, 2008-09 ,pp. : 34-38

Karger

Access to resources Recommend Favorite

Duration of Stable Disease Is Associated with Overall Survival in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib

By  

Digestive Diseases, Vol. 32, Iss. 6, 2014-10 ,pp. : 705-710

Karger

Access to resources Recommend Favorite

Decreased Blood Flow after Sorafenib Administration Is an Imaging Biomarker to Predict Overall Survival in Patients with Advanced Hepatocellular Carcinoma

By  

Digestive Diseases, Vol. 32, Iss. 6, 2014-10 ,pp. : 733-739

Karger

Access to resources Recommend Favorite

Novel Pretreatment Scoring Incorporating C-reactive Protein to Predict Overall Survival in Advanced Hepatocellular Carcinoma with Sorafenib Treatment

By  

Liver Cancer, Vol. 5, Iss. 4, 2016-09 ,pp. : 257-268

Karger

Access to resources Recommend Favorite

The Overall Survival of Patients with Hepatocellular Carcinoma Correlates with the Newly Defined Time to Progression after Transarterial Chemoembolization

By  

Liver Cancer, Vol. 6, Iss. 3, 2017-05 ,pp. : 227-235

Karger

Access to resources Recommend Favorite